193 related articles for article (PubMed ID: 26526944)
1. 2-Hydoxyglutarate: D/Riving Pathology in gLiomaS.
Wahl DR; Venneti S
Brain Pathol; 2015 Nov; 25(6):760-8. PubMed ID: 26526944
[TBL] [Abstract][Full Text] [Related]
2. Molecular biology and novel therapeutics for IDH mutant gliomas: The new era of IDH inhibitors.
Kitagawa Y; Kobayashi A; Cahill DP; Wakimoto H; Tanaka S
Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189102. PubMed ID: 38653436
[TBL] [Abstract][Full Text] [Related]
3. Metabolism, Activity, and Targeting of D- and L-2-Hydroxyglutarates.
Ye D; Guan KL; Xiong Y
Trends Cancer; 2018 Feb; 4(2):151-165. PubMed ID: 29458964
[TBL] [Abstract][Full Text] [Related]
4. Rapid Conversion of Mutant IDH1 from Driver to Passenger in a Model of Human Gliomagenesis.
Johannessen TA; Mukherjee J; Viswanath P; Ohba S; Ronen SM; Bjerkvig R; Pieper RO
Mol Cancer Res; 2016 Oct; 14(10):976-983. PubMed ID: 27430238
[TBL] [Abstract][Full Text] [Related]
5. MR-detectable metabolic biomarkers of response to mutant IDH inhibition in low-grade glioma.
Molloy AR; Najac C; Viswanath P; Lakhani A; Subramani E; Batsios G; Radoul M; Gillespie AM; Pieper RO; Ronen SM
Theranostics; 2020; 10(19):8757-8770. PubMed ID: 32754276
[TBL] [Abstract][Full Text] [Related]
6. Advances in the Immunotherapeutic Potential of Isocitrate Dehydrogenase Mutations in Glioma.
Tang F; Pan Z; Wang Y; Lan T; Wang M; Li F; Quan W; Liu Z; Wang Z; Li Z
Neurosci Bull; 2022 Sep; 38(9):1069-1084. PubMed ID: 35670952
[TBL] [Abstract][Full Text] [Related]
7. Metabolic modulation of epigenetics in gliomas.
Venneti S; Thompson CB
Brain Pathol; 2013 Mar; 23(2):217-21. PubMed ID: 23432648
[TBL] [Abstract][Full Text] [Related]
8. A comparison of 2-hydroxyglutarate detection at 3 and 7 T with long-TE semi-LASER.
Berrington A; Voets NL; Larkin SJ; de Pennington N; Mccullagh J; Stacey R; Schofield CJ; Jezzard P; Clare S; Cadoux-Hudson T; Plaha P; Ansorge O; Emir UE
NMR Biomed; 2018 Mar; 31(3):. PubMed ID: 29315915
[TBL] [Abstract][Full Text] [Related]
9. 2-Hydroxyglutarate-Mediated Autophagy of the Endoplasmic Reticulum Leads to an Unusual Downregulation of Phospholipid Biosynthesis in Mutant IDH1 Gliomas.
Viswanath P; Radoul M; Izquierdo-Garcia JL; Ong WQ; Luchman HA; Cairncross JG; Huang B; Pieper RO; Phillips JJ; Ronen SM
Cancer Res; 2018 May; 78(9):2290-2304. PubMed ID: 29358170
[TBL] [Abstract][Full Text] [Related]
10. Metabolic adaptations in cancers expressing isocitrate dehydrogenase mutations.
Hvinden IC; Cadoux-Hudson T; Schofield CJ; McCullagh JSO
Cell Rep Med; 2021 Dec; 2(12):100469. PubMed ID: 35028610
[TBL] [Abstract][Full Text] [Related]
11.
Kayabolen A; Yilmaz E; Bagci-Onder T
Biomedicines; 2021 Jul; 9(7):. PubMed ID: 34356864
[TBL] [Abstract][Full Text] [Related]
12. D-2-hydroxyglutarate regulates human brain vascular endothelial cell proliferation and barrier function.
Cao C; Zhang L; Sorensen MD; Reifenberger G; Kristensen BW; McIntyre TM; Lin F
J Neuropathol Exp Neurol; 2023 Oct; 82(11):921-933. PubMed ID: 37740942
[TBL] [Abstract][Full Text] [Related]
13. Radiosensitization of IDH-Mutated Gliomas through ZMYND8 - a Pathway to Improved Outcomes.
Sachdev S; Dmello C; Sonabend AM
Clin Cancer Res; 2023 May; 29(9):1648-1650. PubMed ID: 36826993
[TBL] [Abstract][Full Text] [Related]
14. Registered report: Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases.
Evans B; Griner E;
Elife; 2015 Jul; 4():e07420. PubMed ID: 26231040
[TBL] [Abstract][Full Text] [Related]
15. Rotenone Stereospecifically Increases (S)-2-Hydroxyglutarate in SH-SY5Y Neuronal Cells.
Worth AJ; Gillespie KP; Mesaros C; Guo L; Basu SS; Snyder NW; Blair IA
Chem Res Toxicol; 2015 May; 28(5):948-54. PubMed ID: 25800467
[TBL] [Abstract][Full Text] [Related]
16. A biosensor for D-2-hydroxyglutarate in frozen sections and intraoperative assessment of IDH mutation status.
Zhang W; Yang M; Wang G; Ou S; Hu J; Liu J; Lei Y; Kang Z; Wang F; Liu J; Ma C; Wang C; Gao C; Tang D
Biosens Bioelectron; 2024 Mar; 247():115921. PubMed ID: 38104390
[TBL] [Abstract][Full Text] [Related]
17. Oncometabolite 2-hydroxyglutarate regulates anti-tumor immunity.
Cai M; Zhao J; Ding Q; Wei J
Heliyon; 2024 Jan; 10(2):e24454. PubMed ID: 38293535
[TBL] [Abstract][Full Text] [Related]
18. Blood-brain barrier disruption defines the extracellular metabolome of live human high-grade gliomas.
Riviere-Cazaux C; Carlstrom LP; Rajani K; Munoz-Casabella A; Rahman M; Gharibi-Loron A; Brown DA; Miller KJ; White JJ; Himes BT; Jusue-Torres I; Ikram S; Ransom SC; Hirte R; Oh JH; Elmquist WF; Sarkaria JN; Vaubel RA; Rodriguez M; Warrington AE; Kizilbash SH; Burns TC
Commun Biol; 2023 Jun; 6(1):653. PubMed ID: 37340056
[TBL] [Abstract][Full Text] [Related]
19. An enzymic l-2-hydroxyglutarate biosensor based on l-2-hydroxyglutarate dehydrogenase from Azoarcus olearius.
Hou S; Kang Z; Liu Y; Lü C; Wang X; Wang Q; Ma C; Xu P; Gao C
Biosens Bioelectron; 2024 Jan; 243():115740. PubMed ID: 37862756
[TBL] [Abstract][Full Text] [Related]
20. Dual-Knockout of Mutant Isocitrate Dehydrogenase 1 and 2 Subtypes Towards Glioma Therapy: Structural Mechanistic Insights on the Role of Vorasidenib.
Poonan P; Agoni C; Soliman MES
Chem Biodivers; 2021 May; ():. PubMed ID: 33982420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
